Report Categories
View AllRecent Articles
View All
Memorial Day Market Closures What Investors Need to Know
BJs Wholesale Revamps Store Strategy as Consumer Spending Softens
SpaceX Delays Starship Launch Amid Potential RecordBreaking IPO Plans
Technical Analysis Suggests Bullish IntermediateTerm Outlook
Workday WDAY Attracts Analyst Attention as a Potentially Undervalued AI Play
AVBH Q1 2026 Earnings EPS Surpasses Estimates by 275 Stock Slightly Declines
REG Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Reaction
Bristow Group VTOL Q1 2026 Earnings EPS Miss Drives Stock Decline Amid Operational Challenges
Green Brick Partners Q1 2026 Earnings EPS Beats Estimates by 153 Amid Mixed Stock Reaction
PSEC Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Falls Short
BlackRock Credit Allocation Income Trust BTZ Edges Higher as Income Investors Test Resistance
Tucows Inc TCX Holds Steady Near Support as Trading Volume Remains Subdued
Kemper Corporation KMPR Holds Near Resistance Amid Modest Gains
Northann Corp NCL Slips 276 as Stock Tests Key Support at 015
Fed Dissenters Object to Rate Cut Signals in Latest Policy Statement
Brookings Research Sheds Light on Data Center Employment Impact
General Motors Reveals New AllElectric Cadillac Vistiq with 300Mile Range
Fintech Firm Mercury Reaches 52 Billion Valuation Up 49 in 14 Months
External Links
President Trump Signals Iran Deal Progress Strait of Hormuz Opening Tesla AI Stocks Approach Buy Points
SNEX Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction
Kemper Corporation KMPR Declines Nearly 2 Approaching Key Support at 2578
NovaBay Pharmaceuticals NBY Jumps 226 as Trading Volume Surges
Ready Capital RC Slides to 178 Support and Resistance Levels in Focus
GPGI Inc GPGI Rallies 385 Testing Key Resistance Level Near 1304
Kratos Defense Security Solutions KTOS Extends Gains Defense Sector Momentum Lifts Stock to 5520
Gesher Acquisition Corp II GSHR Holds Steady Near 1039 as SPAC Sector Watches for Catalyst
Aberdeen India Fund IFN Holds Steady Near Resistance Amid Modest Uptick
Addex Therapeutics ADXN Holds Gains Amid Biotech Sector Momentum